News

Clinical Trials Arena on MSN6d
First subject dosed in Cellarity’s trial of CLY-124 for sickle cell disease
Cellarity has dosed the first subject in a Phase I study of oral medication, CLY-124, to treat sickle cell disease (SCD).
The Punch on MSN13d
Sickle Cell and early diagnosis: Recognising signs of SCD in infants
Sickle cell disease is one of the most common inherited blood disorders worldwide, with a particularly heavy burden in sub-Saharan Africa. Every year, hundreds of thousands of infants are born with ...
Johns Hopkins Medicine9d
No More Pain: Breakthrough Sickle Cell Treatment from Johns Hopkins Offers Curative Potential
Extreme pain, known as a pain crisis, is one of the hallmark symptoms of SCD. With frequent hospitalizations, chronic pain ...
BlackDoctor.org13d
Sickle Cell Gene Therapy Clinical Trials: What Black People Should Know
With gene therapy in the works, clinical trials for sickle cell disease still lack Black American participants.
Sickle Cell Disease News9d
BEAM-101 shows sustained benefits as treatment for sickle cell
BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...
Open Access Government6d
WHO issues first global guideline for pregnant women with sickle cell disease
The World Health Organization has released its first-ever global guideline on the management of sickle cell disease during ...